Climate and sustainability

As global health systems encounter increasing pressure from climate change, conflict, and displacement, long-acting technologies are emerging as a potential solution to expand treatment access for underserved populations. CELT Global Health are conducting a literature review to explore the viability of long-acting technologies, for use in low- and middle- income countries (LMICs) that are facing systemic instability and environmental disruption.

Project overview

The literature review explores the viability of long-acting technologies in displaced, climate-affected, and underserved populations.

It mainly focuses on HIV, tuberculosis (including latent TB infection), and malaria, while also drawing insights from other diseases. The analysis combines peer-reviewed evidence and grey literature from global health sources, including the World Health Organization, Medicines Patent Pool, Treatment Action Group, and others.

Objectives

The primary aims are to:

Determine whether long-acting technologies can offer scalable, resilient alternatives to daily oral medication
Identify barriers to long-acting technologies access and implementation in underserved settings
Evaluate environmental and regulatory risks associated with long-acting technologies
Illustrate evidence gaps to inform future Unitaid investment and policy work.

Awarding body

This work is supported by global health agency Unitaid.

The Unitaid logo is the organisation name written above the words

(2020-38-LONGEVITY)

Related publications

The findings will inform Unitaid’s Access and Climate and Health Strategy, and are being prepared for internal dissemination including strategy briefings, stakeholder workshops, and meetings with global partners.